Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Dinesh Mondal, Shinjiro Hamano, Golam Hasnain & Abhay R Satoskar. (2014) Challenges for management of post kala-azar dermal leishmaniasis and future directions. Research and Reports in Tropical Medicine 5, pages 105-111.
Read now
Read now
Manica Balasegaram, Koert Ritmeijer, Maria Angeles Lima, Sakib Burza, Gemma Ortiz Genovese, Barbara Milani, Sara Gaspani, Julien Potet & François Chappuis. (2012) Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opinion on Emerging Drugs 17:4, pages 493-510.
Read now
Read now
Smriti Mondal, Pradyot Bhattacharya & Nahid Ali. (2010) Current diagnosis and treatment of visceral leishmaniasis. Expert Review of Anti-infective Therapy 8:8, pages 919-944.
Read now
Read now
Articles from other publishers (50)
Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar & Fabiana Alves. (2023) Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study. PLOS Neglected Tropical Diseases 17:11, pages e0011780.
Crossref
Crossref
Paul M. Kaye, Greg Matlashewski, Sakshi Mohan, Epke Le Rutte, Dinesh Mondal, Ali Khamesipour & Stefano Malvolti. (2023) Vaccine value profile for leishmaniasis. Vaccine 41, pages S153-S175.
Crossref
Crossref
Awnish Kumar, Vishal Kumar Singh, Rahul Tiwari, Prasoon Madhukar, Rajneesh, Shashi Kumar, Vibhav Gautam, Christian Engwerda, Shyam Sundar & Rajiv Kumar. (2023) Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination. Frontiers in Immunology 14.
Crossref
Crossref
Evdoxia Panou, Leonidas Marinos, Evangelia Piperaki, Magda Migkou, Alexander J Stratigos & Vasiliki Nikolaou. (2023) Post-kala-azar dermal leishmaniasis manifestation in a Mediterranean immunosuppressed patient: a rare incident. Clinical and Experimental Dermatology 48:7, pages 834-836.
Crossref
Crossref
V. Kumar, Maxima Madhu & Krishna Murti. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
389
406
.
Shobha Kumari, Vikash Kumar, Ritesh Kumar Tiwari, Vidyanand Ravidas, Krishna Pandey & Ashish Kumar. (2022) Amphotericin B: A drug of choice for Visceral Leishmaniasis. Acta Tropica 235, pages 106661.
Crossref
Crossref
Gert-Jan Wijnant, Franck Dumetz, Laura Dirkx, Dimitri Bulté, Bart Cuypers, Katrien Van Bocxlaer & Sarah Hendrickx. (2022) Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Frontiers in Tropical Diseases 3.
Crossref
Crossref
Charles Lacey, Ahmed Musa, El Tahir Khalil, Brima Younis, Mohamed Osman, Rebecca Wiggins, Ada Keding & Paul Kaye. (2022) LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasis. Wellcome Open Research 7, pages 200.
Crossref
Crossref
Eduard E. Zijlstra. (2021) Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Brima M. Younis, Mohamed Osman, Eltahir A.G. Khalil, Francesco Santoro, Simone Furini, Rebecca Wiggins, Ada Keding, Monica Carraro, Anas E.A. Musa, Mujahid A.A. Abdarahaman, Laura Mandefield, Martin Bland, Toni Aebischer, Rhian Gabe, Alison M. Layton, Charles J.N. Lacey, Paul M. Kaye & Ahmed M. Musa. (2021) Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan. Molecular Therapy 29:7, pages 2366-2377.
Crossref
Crossref
Krishna Pandey, Biplab PalNiyamat Ali SiddiquiChandra Shekhar LalVahab AliSanjiva BimalAshish KumarNeena VermaVidya Nand Rabi Das, Shubhankar Kumar SinghRoshan Kamal Topno & Pradeep Das. (2021) A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis. Indian Journal of Dermatology, Venereology and Leprology 87, pages 34-41.
Crossref
Crossref
Mallikarjuna Rao Gedda, Bhawana Singh, Dhiraj Kumar, Abhishek Kumar Singh, Prasoon Madhukar, Shreya Upadhyay, Om Prakash Singh & Shyam Sundar. (2020) Post kala-azar dermal leishmaniasis: A threat to elimination program. PLOS Neglected Tropical Diseases 14:7, pages e0008221.
Crossref
Crossref
Andreas H Groll, Bart J A Rijnders, Thomas J Walsh, Jill Adler-Moore, Russell E Lewis & Roger J M Brüggemann. (2019) Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B. Clinical Infectious Diseases 68:Supplement_4, pages S260-S274.
Crossref
Crossref
Julio Heras-Mosteiro, Begoña Monge-Maillo, Mariona Pinart, Patricia Lopez Pereira, Ludovic Reveiz, Emely Garcia-Carrasco, Pedro Campuzano Cuadrado, Ana Royuela, Irene Mendez Roman & Rogelio López-Vélez. (2017) Interventions for Old World cutaneous leishmaniasis. Cochrane Database of Systematic Reviews 2017:12.
Crossref
Crossref
Julio Heras-Mosteiro, Begoña Monge-Maillo, Mariona Pinart, Patricia Lopez Pereira, Emely Garcia-Carrasco, Pedro Campuzano Cuadrado, Ana Royuela, Irene Mendez Roman & Rogelio López-Vélez. (2017) Interventions for Old World cutaneous leishmaniasis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Vidya Nand Rabi Das, Niyamat Ali Siddiqui, Biplab Pal, Chandra Shekhar Lal, Neena Verma, Ashish Kumar, Rakesh Bihari Verma, Dhirendra Kumar, Pradeep Das & Krishna Pandey. (2017) To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL). PLOS ONE 12:3, pages e0174497.
Crossref
Crossref
Débora V.C. Mendonça, Letícia M.R. Lage, Daniela P. Lage, Miguel A. Chávez-Fumagalli, Fernanda Ludolf, Bruno M. Roatt, Daniel Menezes-Souza, André A.G. Faraco, Rachel O. Castilho, Carlos A.P. Tavares, José Mário Barichello, Mariana C. Duarte & Eduardo A.F. Coelho. (2016) Poloxamer 407 (Pluronic® F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis. Experimental Parasitology 169, pages 34-42.
Crossref
Crossref
Charles Abongomera, Francis Gatluak, Jozefine Buyze & Koert Ritmeijer. (2016) A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study. PLOS ONE 11:9, pages e0163047.
Crossref
Crossref
Lynne Shore Garcia. 2016. Diagnostic Medical Parasitology. Diagnostic Medical Parasitology
778
809
.
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
324
352
.
V. Ramesh & Prashant Verma. 2016. Kala Azar in South Asia. Kala Azar in South Asia
67
77
.
Atia M. Atia, Ann Mumina, Katherine Tayler‐Smith, Philippa Boulle, Gabriel Alcoba, Mousab Siddig Elhag, Mubarak Alnour, Safieh Shah, François Chappuis, Johan Griensven & Rony Zachariah. (2015) Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan. Tropical Medicine & International Health 20:12, pages 1674-1684.
Crossref
Crossref
Alan J. Magill. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3091
3107.e4
.
Ulrika Marking, Margriet den Boer, Asish Kumar Das, Elshafie Mohamed Ahmed, Victoria Rollason, Be-Nazir Ahmed, Robert N. Davidson & Koert Ritmeijer. (2014) Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh—A Case Report. PLoS Neglected Tropical Diseases 8:6, pages e2864.
Crossref
Crossref
Shyam Sundar, Anup Singh & Om Prakash Singh. (2014) Strategies to Overcome Antileishmanial Drugs Unresponsiveness. Journal of Tropical Medicine 2014, pages 1-7.
Crossref
Crossref
Philippe Desjeux, Raj Shankar Ghosh, Pritu Dhalaria, Nathalie Strub-Wourgaft & Ed E Zijlstra. (2013) Report of the Post Kala-Azar Dermal Leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27–29 June 2012. Parasites & Vectors 6:1.
Crossref
Crossref
Poonam Salotra, Ruchi Singh & Karin Seifert. 2013. Trypanosomatid Diseases. Trypanosomatid Diseases
1
15
.
A. M. Musa, E. A. G. Khalil, B. M. Younis, M. E. E. Elfaki, M. Y. Elamin, A. O. A. Adam, H. A. A. Mohamed, M. M. M. Dafalla, A. A. Abuzaid & A. M. El-Hassan. (2013) Treatment-Based Strategy for the Management of Post-Kala-Azar Dermal Leishmaniasis Patients in the Sudan. Journal of Tropical Medicine 2013, pages 1-5.
Crossref
Crossref
Eltahir Awad Gasim Khalil, Selma Abdelmoneim Khidir, Ahmed Mudawi Musa, Brema Younis Musa, Mona Elfaki Eltahir Elfaki, Abdelgadir Mohamed Yousif Elkadaru, Edward Zijlstra & Ahmed Mohamed El-Hassan. (2013) Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients. Journal of Tropical Medicine 2013, pages 1-7.
Crossref
Crossref
Amber Read, Ivy Hurwitz & Ravi Durvasula. 2013. Dynamic Models of Infectious Diseases. Dynamic Models of Infectious Diseases
95
138
.
Abeer H.A. Mohamed-Ahmed, Stephen Brocchini & Simon L. Croft. (2012) Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis. Current Opinion in Infectious Diseases 25:6, pages 695-702.
Crossref
Crossref
Debanjan Mukhopadhyay, Nilay Kanti Das, Sritama De Sarkar, Alak Manna, Dwijendra Nath Ganguly, Joyashree Nath Barbhuiya, Arup K. Maitra, Avijit Hazra & Mitali Chatterjee. (2012) Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 106:11, pages 668-676.
Crossref
Crossref
Caryn Bern, Kazi Mizanur Rahman, Masayo Ozaki, Anisur Rahman, Shamim Islam & Stephen P. Luby. (2011) Economic Consequences of Post–Kala-Azar Dermal Leishmaniasis in a Rural Bangladeshi Community. The American Journal of Tropical Medicine and Hygiene 85:3, pages 528-534.
Crossref
Crossref
M. Solomon, F. Pavlotsky, E. Leshem, M. Ephros, H. Trau & E. Schwartz. (2011) Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica. Journal of the European Academy of Dermatology and Venereology 25:8, pages 973-977.
Crossref
Crossref
Philippe Desjeux & V. Ramesh. 2011. Kala Azar in South Asia. Kala Azar in South Asia
111
124
.
Sudipto Ganguly, Nilay Kanti Das, Joyashree Nath Barbhuiya & Mitali Chatterjee. (2010) Post-kala-azar dermal leishmaniasis - an overview. International Journal of Dermatology 49:8, pages 921-931.
Crossref
Crossref
Sujay Khandpur, Pankaj Chaturvedi, Uttam Kumar, Binod K. Khaitan, Jyotish C. Samantaray & Vinod K. Sharma. (2010) Oral miltefosine in post-kala-azar dermal leishmaniasis - experience in three cases. International Journal of Dermatology 49:5, pages 565-569.
Crossref
Crossref
ALAN J. MAGILL. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3463
3480
.
Dirk M. Elston. 2010. Therapy of Skin Diseases. Therapy of Skin Diseases
181
189
.
Consuelo V. David & Noah Craft. (2009) Cutaneous and mucocutaneous leishmaniasis. Dermatologic Therapy 22:6, pages 491-502.
Crossref
Crossref
Peter K. Ngure, Albert Kimutai, Zipporah W. Ng'ang'a, Geoffrey Rukunga & Willy K. Tonui. (2009) A review of Leishmaniasis in Eastern Africa. Journal of Nanjing Medical University 23:2, pages 79-86.
Crossref
Crossref
Giulia Bonacucina, Marco Cespi, Monica Misici-Falzi & Giovanni F. Palmieri. (2009) Colloidal soft matter as drug delivery system. Journal of Pharmaceutical Sciences 98:1, pages 1-42.
Crossref
Crossref
Andreas H. Groll & Thomas J. Walsh. 2008.
Aspergillus fumigatus
and Aspergillosis
.
Aspergillus fumigatus
and Aspergillosis
389
415
.
Urbà González, Mariona Pinart, Ludovic Reveiz & Jorge Alvar. (2008) Interventions for Old World cutaneous leishmaniasis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ahmed Mudawi Musa, Eltahir Awad Gasim Khalil, Fawzi Abd Elrahim Mahgoub, Sara Hamad Hassab Elgawi, Farroukh Modabber, Abd Elgadir Mohamed Yousif Elkadaru, Mona Hussein Aboud, Sassan Noazin, Hashim Warsama Ghalib & Ahmed Mohamed El-Hassan. (2008) Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 102:1, pages 58-63.
Crossref
Crossref
Andreas H. Groll & Thomas J. Walsh. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
316
335
.
Hashim Ghalib & Farrokh Modabber. (2007) Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis. Kinetoplastid Biology and Disease 6:1.
Crossref
Crossref
Michal Solomon, Sharon Baum, Aviv Barzilai, Alon Scope, Henry Trau & Eli Schwartz. (2007) Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis. Journal of the American Academy of Dermatology 56:4, pages 612-616.
Crossref
Crossref
Lynne Shore Garcia. 2007. Diagnostic Medical Parasitology. Diagnostic Medical Parasitology
190
217
.
Jorge Alvar, Simon Croft & Piero Olliaro. 2006. Control of Human Parasitic Diseases. Control of Human Parasitic Diseases
223
274
.